KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medpace Holdings (MEDP) EPS (Weighted Average and Diluted): 2015-2025

Historic EPS (Weighted Average and Diluted) for Medpace Holdings (MEDP) over the last 10 years, with Sep 2025 value amounting to $3.86.

  • Medpace Holdings' EPS (Weighted Average and Diluted) rose 28.24% to $3.86 in Q3 2025 from the same period last year, while for Sep 2025 it was $14.30, marking a year-over-year increase of 25.22%. This contributed to the annual value of $12.63 for FY2024, which is 42.23% up from last year.
  • Latest data reveals that Medpace Holdings reported EPS (Weighted Average and Diluted) of $3.86 as of Q3 2025, which was up 24.52% from $3.10 recorded in Q2 2025.
  • Medpace Holdings' EPS (Weighted Average and Diluted)'s 5-year high stood at $3.86 during Q3 2025, with a 5-year trough of $1.06 in Q2 2021.
  • For the 3-year period, Medpace Holdings' EPS (Weighted Average and Diluted) averaged around $2.92, with its median value being $3.01 (2024).
  • Data for Medpace Holdings' EPS (Weighted Average and Diluted) shows a peak YoY increase of 65.62% (in 2021) and a maximum YoY decrease of 1.49% (in 2021) over the last 5 years.
  • Over the past 5 years, Medpace Holdings' EPS (Weighted Average and Diluted) (Quarterly) stood at $1.32 in 2021, then surged by 59.09% to $2.10 in 2022, then grew by 17.14% to $2.46 in 2023, then spiked by 49.19% to $3.67 in 2024, then climbed by 28.24% to $3.86 in 2025.
  • Its last three reported values are $3.86 in Q3 2025, $3.10 for Q2 2025, and $3.67 during Q1 2025.